Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Lacey III currently holds 228,509 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Lacey III has been a net neutral trader of PVCT stock. They have purchased $0 and sold $0 worth of shares.
John Lacey III's most recent insider trade was on Jun 30, 2026, when they sold 48,917 shares at $0.00 per share.
John Lacey III serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT). They have executed 3 insider transactions totaling $0 over their tenure at the company.
John Lacey III holds the position of Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
John Lacey III has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Lacey III was on Jun 30, 2026, when they purchased $0 worth of PVCT shares. This transaction involved 48,917 shares at N/A per share.
John Lacey III currently owns 228,509 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Lacey III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Lacey III has 3 Form 4 filings on record as an insider at PROVECTUS BIOPHARMACEUTICALS, INC..
Set alerts for John Lacey III and 40,000+ other insiders.